Moreover, we demonstrated that METTL14 promoted MDS cell proliferation by enhancing the expression of the downstream target SETBP1 through formation of METTL3-METTL14 heterodimer, which subsequently activating the PI3K-AKT signaling pathway. The gene discussed is SETBP1; the disease is myelodysplastic syndrome.